These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23636173)

  • 1. The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection.
    Hu MC; Shi M; Cho HJ; Zhang J; Pavlenco A; Liu S; Sidhu S; Huang LJ; Moe OW
    Kidney Int; 2013 Sep; 84(3):468-81. PubMed ID: 23636173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signals mediating Klotho-induced neuroprotection in hippocampal neuronal cells.
    Cheng MF; Chen LJ; Niu HS; Yang TT; Lin KC; Cheng JT
    Acta Neurobiol Exp (Wars); 2015; 75(1):60-71. PubMed ID: 25856523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue protection by erythropoietin: new findings in a moving field.
    Nangaku M
    Kidney Int; 2013 Sep; 84(3):427-9. PubMed ID: 23989353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO; Harris KW; Forget BG
    Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
    Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis.
    Ueda F; Tago K; Tamura H; Funakoshi-Tago M
    J Biol Chem; 2017 Feb; 292(5):1826-1846. PubMed ID: 27998978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment.
    Xie Z; Chen F; Wu X; Zhuang C; Zhu J; Wang J; Ji H; Wang Y; Hua X
    Curr Eye Res; 2012 Feb; 37(2):138-44. PubMed ID: 22251399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
    Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
    Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2.
    Grebien F; Kerenyi MA; Kovacic B; Kolbe T; Becker V; Dolznig H; Pfeffer K; Klingmüller U; Müller M; Beug H; Müllner EW; Moriggl R
    Blood; 2008 May; 111(9):4511-22. PubMed ID: 18239084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
    Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
    Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT5 as a Key Protein of Erythropoietin Signalization.
    Tóthová Z; Tomc J; Debeljak N; Solár P
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of erythropoietin receptor activity on angiogenesis, tubular injury, and fibrosis in acute kidney injury: a "U-shaped" relationship.
    Shi M; Flores B; Li P; Gillings N; McMillan KL; Ye J; Huang LJ; Sidhu SS; Zhong YP; Grompe MT; Streeter PR; Moe OW; Hu MC
    Am J Physiol Renal Physiol; 2018 Apr; 314(4):F501-F516. PubMed ID: 29187371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
    Landau D; London L; Bandach I; Segev Y
    PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT5 activation is critical for the transformation mediated by myeloproliferative disorder-associated JAK2 V617F mutant.
    Funakoshi-Tago M; Tago K; Abe M; Sonoda Y; Kasahara T
    J Biol Chem; 2010 Feb; 285(8):5296-307. PubMed ID: 20028972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
    Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
    Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
    Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.
    Sasaki A; Yasukawa H; Shouda T; Kitamura T; Dikic I; Yoshimura A
    J Biol Chem; 2000 Sep; 275(38):29338-47. PubMed ID: 10882725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
    Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
    Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
    Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.